An individual who corresponds to any of the following:

Ovarian cancer patients after initial chemotherapy (maintenance therapy)

Patients with platinum antineoplastic drug sensitive recurrent ovarian cancer (maintenance therapy)

Recurrent ovarian cancer with platinum-sensitive homologous recombination repair defects.

A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice